You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Dow
Mallinckrodt
Express Scripts
Moodys

Last Updated: April 2, 2020

DrugPatentWatch Database Preview

PRED FORTE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Pred Forte, and when can generic versions of Pred Forte launch?

Pred Forte is a drug marketed by Allergan and is included in one NDA.

The generic ingredient in PRED FORTE is prednisolone acetate. There are eighty-eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the prednisolone acetate profile page.

Drug patent expirations by year for PRED FORTE
Drug Prices for PRED FORTE

See drug prices for PRED FORTE

Drug Sales Revenue Trends for PRED FORTE

See drug sales revenues for PRED FORTE

Pharmacology for PRED FORTE
Synonyms for PRED FORTE
(11beta)-11,17-dihydroxy-3,20-dioxopregna-1,4-dien-21-yl acetate
[2-[(8S,9S,10R,11S,13S,14S,17R)-10,13-dimethyl-11,17-bis(oxidanyl)-3-oxidanylidene-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxidanylidene-ethyl] ethanoate
[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
037P710
11b,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-acetate
11beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione 21-acetate
2-((1S,10S,11S,15S,17S,2R,14R)-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8 .7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-14-yl)-2-oxoethyl acetate
2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate
21-Acetoxy-1,4-pregnadiene-11beta,17alpha-diol-3,20-dione
4-08-00-03468 (Beilstein Handbook Reference)
52-21-1
8B2807733D
A828982
AB00443788_13
AB00443788-11
AB2000666
AC-2176
acetic acid [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] ester
AKOS007930677
AKOS015960469
AS-11673
BCP18958
Blephamide Liquifilm
Blephamide S.O.P.
BRN 3111798
C08180
CAS-52-21-1
Cetapred Ointment
CHEBI:8380
CHEMBL1152
component of Composone
component of Isopto Cetapred
component of Metimyd
component of Neo-Delta-Cortef
Cormalone
Cortipred
CS-4642
D00980
DB15566
Delcort-E
Deltilen
DSSTox_CID_3502
DSSTox_GSID_23502
DSSTox_RID_77056
DTXSID3023502
Durapred
Econopred
Econopred (TN)
Econopred Plus
EINECS 200-134-1
Flo-Pred
HMS2234F18
HMS3259O07
HY-B1214
LRJOMUJRLNCICJ-JZYPGELDSA-N
LS-118501
Meticortelone acetate
MLS000028512
MLS001148097
MLS002207146
MLS002548870
NC00470
NCGC00021925-03
NCGC00021925-05
NCGC00094765-01
Nisolone
NSC 10966
NSC-10966
NSC10966
Omnipred
Opera_ID_332
P1283
Pred forte (TN)
Pred Forte TM 1%
Pred Mild
Pred-Forte
Pred-G Liquifilm
Pred-G S.O.P
Pred-G S.O.P.
Predalone 50
Prediacortine
Predicort
Prednelan-N
Prednidoren
Prednisolone (21-acetate)
Prednisolone 21-acetate
Prednisolone 21-acetate, >=97%
Prednisolone 21-acetate, VETRANAL(TM), analytical standard
prednisolone acetate
Prednisolone acetate (JP17/USP/INN)
Prednisolone acetate (Omnipred)
Prednisolone acetate [BAN:JAN]
Prednisolone acetate [USP:JAN]
Prednisolone acetate for peak identification, European Pharmacopoeia (EP) Reference Standard
Prednisolone acetate, British Pharmacopoeia (BP) Reference Standard
Prednisolone acetate, European Pharmacopoeia (EP) Reference Standard
Prednisolone Acetate, Pharmaceutical Secondary Standard; Certified Reference Material
Prednisolone acetate, United States Pharmacopeia (USP) Reference Standard
PREDNISOLONE-21-ACETATE
Prednisolone-acetate-Omnipred
PrednisoloneAcetate
Predonine injection
Pregna-1,20-dione, 11.beta.,17,21-trihydroxy-, 21-acetate
Pregna-1,20-dione, 21-(acetyloxy)-11,17-dihydroxy-, (11.beta.)-
Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-, 21-acetate
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-, 21-acetate
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-, 21-acetate (8CI)
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-, (11b)-
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-, (11beta)-
Prenema
Pricortin
Q-201614
Q27108063
s2570
SCHEMBL7999
SMR000058326
ST075202
ster
Sterane IM and IA
Supercortyl
Tox21_111328
Tox21_111328_1
UNII-8B2807733D
Vasocidin Ointment
ZINC3875348

US Patents and Regulatory Information for PRED FORTE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan PRED FORTE prednisolone acetate SUSPENSION/DROPS;OPHTHALMIC 017011-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Dow
Mallinckrodt
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.